Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1–25 of 566 matching trials (filtered from 7,816) · page 1 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons NCT05048966 Group Wellness Class 1; Group Wellness Class 2 Runs in: United States · 1 site |
NA other |
RECRUITING | 360 | Kessler Foundation OTHER |
2026-09-21 |
|
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 NCT05456503 [18F]-PI-2620 Runs in: United States · 1 site |
PHASE3 other |
RECRUITING | 72 | University of Pennsylvania OTHER |
2026-09-21 |
|
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism NCT06041789 Donepezil; Memantine Runs in: United States · 1 site |
PHASE2 symptomatic-cholinergic |
RECRUITING | 45 | Duke University OTHER |
2026-09-21 |
|
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease NCT06847321 LHP588; LHP588; Placebo Drug Runs in: United States · 39 sites |
PHASE2 other |
RECRUITING | 300 | Lighthouse Pharmaceuticals, Inc. INDUSTRY |
2026-09-21 |
|
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging NCT07099053 Runs in: United States · 1 site |
NA other |
RECRUITING | 400 | National Institute on Aging (NIA) NIH |
2026-09-21 |
|
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) NCT07169630 18F-PF974; 18F-florbetaben Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 90 | National Institute of Mental Health (NIMH) NIH |
2026-09-21 |
|
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies NCT07177352 No Intervention Runs in: Argentina; Australia; Brazil; Canada; Chile; China; Denma... · 229 sites |
PHASE3 other |
RECRUITING | 80,000 | Hoffmann-La Roche INDUSTRY |
2026-09-21 |
|
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease NCT07378644 SKY-0515; SKY-0515 Placebo Runs in: Argentina; Brazil; Canada; Chile; Colombia; Georgia; Germ... · 24 sites |
PHASE2|PHASE3 other |
RECRUITING | 400 | Skyhawk Therapeutics, Inc. INDUSTRY |
2026-09-21 |
|
The Gut - PRO Study NCT07413744 Probiotic; Placebo Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 40 | University of Wisconsin, Madison OTHER |
2026-09-21 |
|
Escalating Doses of Memantine in Down Syndrome (MEDS-123) NCT07531940 Memantine Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
NOT_YET_RECRUITING | 25 | University Hospitals Cleveland Medical Center OTHER |
2026-09-21 |
|
Music for Pain and Dementia NCT07602283 Drumming session; Music-listening session Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Yale University OTHER |
2026-09-21 |
|
Comparing Two Acute Care Transition Programs for Older Adults and Their Family Caregivers NCT07661355 Patient-Centered Program; Family Caregiver Enhanced Program Runs in: United States · 4 sites |
NA other |
RECRUITING | 2,560 | Wake Forest University Health Sciences OTHER |
2026-09-21 |
|
Microbiome in Aging of Gut and Brain NCT07799402 Runs in: United States · 1 site |
NA other |
RECRUITING | 700 | University of South Florida OTHER |
2026-09-21 |
|
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease NCT04396873 11C-MC1; 11C-PS13; 18f-florbetaben Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 184 | National Institute of Mental Health (NIMH) NIH |
2026-09-18 |
|
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease NCT07599670 ABBV-1758; Placebo for ABBV-1758; ABBV-1758; Placebo for ABBV-1758 Runs in: China; United States · 13 sites |
PHASE1|PHASE2 other |
RECRUITING | 210 | AbbVie INDUSTRY |
2026-09-18 |
|
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia NCT03225144 Runs in: United States · 1 site |
NA other |
RECRUITING | 360 | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
2026-09-17 |
|
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease NCT05295615 ECHS AD Device Runs in: United States · 1 site |
NA other |
RECRUITING | 40 | Herrick Medical LLC INDUSTRY |
2026-09-17 |
|
Pulsed Electromagnetic Field Treatment With Dementia Patients NCT06862557 ECHS AD Device Runs in: United States · 1 site |
NA other |
RECRUITING | 48 | Herrick Medical LLC INDUSTRY |
2026-09-17 |
|
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2) NCT06976203 KarXT; KarX-EC; Placebo Runs in: Argentina; Australia; Brazil; Finland; France; Germany; G... · 127 sites |
PHASE3 other |
RECRUITING | 586 | Bristol-Myers Squibb INDUSTRY |
2026-09-17 |
|
Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER) NCT07216950 Knowledge and Interpersonal Skills to Develop Enhanced Relationship... Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 260 | Case Western Reserve University OTHER |
2026-09-17 |
|
Pridopidine Phase 3 Study in Huntington's Disease NCT07609108 Pridopidine; Placebo Runs in: Belgium; Canada; Czechia; France; Germany; Italy; Netherl... · 66 sites |
PHASE3 other |
RECRUITING | 400 | Prilenia INDUSTRY |
2026-09-17 |
|
Percepta for Cognitive Optimization NCT07612449 Percepta; Placebo Runs in: United States · 1 site |
NA other |
RECRUITING | 154 | Cerebrum DAO Association OTHER |
2026-09-17 |
|
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin NCT07721467 Psilocybin; Cognitive Training Runs in: United States · 1 site |
PHASE2 other |
NOT_YET_RECRUITING | 200 | National Institute on Aging (NIA) NIH |
2026-09-17 |
|
Adaptango Performance PRocess for Older Adults Community reHabilitation NCT07824128 Adaptango Performance Process (APP) program Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 120 | Emory University OTHER |
2026-09-17 |
|
Advancing Ethical Goals In Society Trial NCT07824245 ACP Counselor Video Program Runs in: United States · 2 sites |
NA other |
NOT_YET_RECRUITING | 12,174 | Tufts Medical Center OTHER |
2026-09-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial